SS
NVO

Steve Schonfeld’s Novo Nordisk NVO Stock Holding History

Steve Schonfeld’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Buy
+38,000
New +$1.63M 0.01% 1116
2025
Q2 		– Sell
-41,000
Closed -$2.85M – 2388
2025
Q1 		$2.85M Buy
+41,000
New +$3.39M 0.02% 778
2023
Q3 		– Sell
-400,000
Closed -$1.16M – 2128
2023
Q2 		$1.16M Buy
+400,000
New +$32.7M 0.01% 921

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Steve Schonfeld's NVO Position: Q2 2026 in Review

Steve Schonfeld reduced its Novo Nordisk (NVO) stake by 87% in Q2 2026, selling an estimated $3.83M and leaving 12,964 shares worth $621K. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

Steve Schonfeld first reported a position in NVO in Q1 2016 and has held it in 22 quarters since. The position peaked at $30.9M in Q3 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Steve Schonfeld held 12,964 shares of Novo Nordisk worth $621K as of Q2 2026.
  • Steve Schonfeld sold 89,076 Novo Nordisk shares in Q2 2026, an estimated $3.83M.
  • Novo Nordisk made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1720 holding.
  • Steve Schonfeld first reported a position in Novo Nordisk in Q1 2016 and has held it in 22 quarters since.
  • Steve Schonfeld's Novo Nordisk position peaked at $30.9M in Q3 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.